{
    "SPADE_UN_18791": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18791",
            "Peptide Name": "GLRC-4 (Synthetic AMPs, variant of GLR-19, Arg-rich; Leu-rich; 2S=S, UCSS1a)",
            "Source": "De novo designed, man-made sequences",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GCRRLCGRLGRRLCRLLCR",
            "Sequence Length": 19,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antiviral",
                "Anti-HIV"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2260.83,
            "PI": 11.61,
            "Hydrophobicity": -0.19,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2011",
                    "Reference": "J AIDS Clinic Res S2:003. doi:10.4172/2155-6113.S2-003.Wang HIV screen project",
                    "Title": "De Novo Design of Antiviral and Antibacterial Peptides with \nVarying Loop Structures"
                }
            ],
            "Frequent Amino Acids": "RLC",
            "Absent Amino Acids": "ADEFHIKMNOPQSTUVWY",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 5,
            "Polar Residues": 11,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "Net Charge": 7,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is poorly similar (89.47%) toGLRC-3. R: 37%; L: 26%.; C: 21%Chemical modification:  two disulfide bond C2-C18, C6-C14.Activity: inhibited HSV-2MS in Vero cells (EC50 69.3 ug/ml); HSV-2MS in Vero cells (EC50 64.7 ug/ml). E. coli (MIC 60 uM); B.subtilis (MIC >120 uM).Toxicity: TC50 >100 ug/ml in CEM-SS cells.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_13423",
                    "Similarity": 1.0,
                    "Sequence": "LLCRVHKKIA"
                },
                {
                    "SPADE_ID": "SPADE_UN_21197",
                    "Similarity": 1.0,
                    "Sequence": "LLCRVHKKIA"
                },
                {
                    "SPADE_ID": "SPADE_UN_18790",
                    "Similarity": 0.8947368421052632,
                    "Sequence": "GLRRLCGRLGRRLCRLLLR"
                }
            ]
        }
    }
}